Biblio

Pentz, Rebecca D. 1 Flamm, Anne L. 2 Sugarman, Jeremy 3 Cohen, Marlene Z. 4,5,6,7 Zhiheng Xu 8 Herbst, Roy S. 9,10 Abbruzzese, James L. 11; Affiliation: 1: Professor, Hematology and Oncology in Research Ethics, Winship Cancer Institute, Emory University, Atlanta, GA 2: Visiting Assistant Professor, Case University School of Law, Cleveland, OH 3: Harvey M. Meyerhoff Professor, Bioethics and Medicine, Berman Institute of Bioethics and Department of Medicine, Johns Hopkins University, Baltimore 4: John S. Dunn, Sr., Distinguished Professor, Oncology Nursing, University of Texas Health Science Center Houston School of Nursing 5: Assistant Dean, University of Texas Health Science Center Houston School of Nursing 6: Chair, Department of Integrative Nursing Care, University of Texas Health Science Center Houston School of Nursing 7: Professor, Department of Symptom Research, University of Texas M.D. Anderson Cancer Center, Houston, TX 8: Biostatician, Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, GA 9: Chief, Section of Thoracic Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 10: Codirector, Phase I Clinical Trials Working Group, University of Texas M.D. Anderson Cancer Center, Houston, TX 11: Chair, Department of GI Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX; Source Info: Jul/Aug2007, Vol. 29 Issue 4, p1; Subject Term: AIDS activists; Subject Term: HEALTH services accessibility; Subject Term: DRUG development; Subject Term: CLINICAL trials; Subject Term: MEDICAL laws & legislation; Subject Term: PUBLIC health administration; Subject Term: UNITED States; Company/Entity: UNITED States. Food & Drug Administration; NAICS/Industry Codes: 923120 Administration of Public Health Programs; Number of Pages: 6p; Document Type: Article